Fetal growth restriction - from observation to intervention.
about
p45 NF-E2 regulates syncytiotrophoblast differentiation by post-translational GCM1 modifications in human intrauterine growth restriction.Effect of vitamin D on the learning and memory ability of FGR rat and NMDA receptor expression in hippocampus.Docosahexaenoic acid supplementation early in pregnancy may prevent deep placentation disorders.Placental histopathological correlates of umbilical artery Doppler velocimetry in pregnancies complicated by fetal growth restriction.IUGR management: new perspectivesCirculating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero.Adenosine A₂a receptors and O₂ sensing in developmentPlacental Insufficiency in Fetuses That Slow in Growth but Are Born Appropriate for Gestational Age: A Prospective Longitudinal StudyFetal umbilical artery Doppler pulsatility index and childhood neurocognitive outcome at 12 years.MR Imaging-derived Oxygen-Hemoglobin Dissociation Curves and Fetal-Placental Oxygen-Hemoglobin Affinities.Early onset fetal growth restriction.Postnatal systemic blood flow in neonates with abnormal fetal umbilical artery Doppler.Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction.Measuring hypoxia-induced RNA in maternal blood: a new way to identify critically hypoxic fetuses in utero?Shining light in dark corners: diagnosis and management of late-onset fetal growth restriction.Impact of cerebral redistribution on neurodevelopmental outcome in small-for-gestational-age or growth-restricted babies: a systematic review.Doppler-based fetal heart rate analysis markers for the detection of early intrauterine growth restriction.Fetal movements as a predictor of health.Changes in fetal Doppler indices as a marker of failure to reach growth potential at term.Slow fetal growth between first and early second trimester ultrasound scans and risk of small for gestational age (SGA) birthCirculating RNA coding genes regulating apoptosis in maternal blood in severe early onset fetal growth restriction and pre-eclampsia.Outcome of severe placental insufficiency with abnormal umbilical artery Doppler prior to fetal viability.Fetal aortic isthmus Doppler measurements for prediction of perinatal morbidity and mortality associated with fetal growth restriction.Male genital abnormalities in intrauterine growth restriction.Increased risks of preterm birth and a low-birth-weight baby in Thai human immunodeficiency virus-positive pregnant women with periodontitis.Magnetic resonance imaging of the placenta identifies placental vascular abnormalities independently of Doppler ultrasound.Amnioinfusion before 26 weeks' gestation for severe fetal growth restriction with oligohydramnios: preliminary pilot study.The underestimation of immaturity in late preterm infants.Placental chorangiosis: the association with oxidative stress and angiogenesis.Impact of Doppler sonography on intrauterine management and neonatal outcome in preterm fetuses with intrauterine growth restriction.Retained placenta is associated with pre-eclampsia, stillbirth, giving birth to a small-for-gestational-age infant, and spontaneous preterm birth: a national register-based study.Pregnancy outcome and placental pathology in small for gestational age neonates in relation to the severity of their growth restriction.The relationship between preoperative fetal head circumference and 2-year cognitive performance after laser surgery for twin-twin transfusion syndrome.Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016).The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.Effects of foetal growth restriction and preterm birth on cardiac morphology and function during infancy.Estimation of the growth rate in fetuses with an abnormal cerebroplacental ratio compared to those with suspected growth restriction without evidence of centralization of blood flow.Cardiotocographic parameters in small-for-gestational-age fetuses: How do they vary from normal at different gestational ages? A study of 11687 fetuses from 25 to 40 weeks of pregnancy.Antenatal taurine supplementation in fetal rats with growth restriction improves neural stem cell proliferation by inhibiting the activities of Rho family factors.The predictive value of lactate peak detected by the magnetic resonance spectroscopy in the brain of growth-restricted fetuses for adverse perinatal outcomes.
P2860
Q33815861-6930D6F7-320A-43C9-AD53-0307C37337BDQ33846645-3EEF511E-51A4-4E1A-A503-74B5CF27A0DAQ33850028-E83AEAD7-A3FE-4564-B6C9-9881ED283B37Q34457607-EEBC12E0-524A-4061-A167-A4332C6B790EQ34761804-90C650C0-C748-4032-BD76-8D9F9BEAC730Q35054999-FA07501D-6083-4E52-8907-DD34086B85EEQ35217420-B1F7E6A9-4D36-44D2-A8DE-6F0EADCA9A2DQ35885014-45F65867-8A1A-4DF9-88EF-93D2BBAFE032Q37027996-D5292CB6-D19A-4A44-85CE-966C4429755AQ37090071-6A890863-B6B6-4076-8B82-41D8C604A502Q37591488-6F7CFE07-E1B2-432A-B00D-D07B674BB8EBQ37657443-D158DCCA-6A4E-4DAA-AFC5-DC24D46289E6Q37869054-7180BFDE-B9A0-4A1F-A542-BA6C6A1F47D1Q38208033-6DC8BE6C-7FD1-4C58-ACAF-C5C506875567Q38307004-0A674712-C2E3-46C4-A83A-8A6DC4417F69Q38356446-6A63EB45-0259-411C-8DBE-816A39489847Q38371952-88502974-F82D-4DB4-B044-02A91ADC2683Q38885018-DDFC3352-591F-4DE6-8F83-4D266D40AE42Q39257934-6B7E7ADD-5767-4993-853E-BCE245345272Q42045298-DF9DD828-4D14-489D-85D1-83C13D4D26A2Q43816234-AADC04C5-8821-409C-801F-AAACAE45E6E2Q43846598-949C2E2B-9341-4AD7-B0FD-358F640FA8B9Q44599422-7BB4EBDA-B093-4FCC-A49C-A2E8B0DA57E2Q44801912-0EF50AD9-2603-464A-814C-B88C785AD119Q45021366-78D3500C-7A3F-4EE5-9596-64708D57C558Q46135897-038C9EA8-B4BD-483E-8633-F76CD06A083AQ46318297-29BF5F8A-47D7-4AF5-94AA-FFB06BFC32F2Q46324141-6DCE5598-9ED9-4E22-9A90-799D7664D5EFQ46325358-A7AC41A1-CCC3-4579-9BE8-750C72AB3451Q46604051-1AE3E7EB-705E-4FA6-B89D-E8881B7AC6C1Q47822335-B53ABD9E-B728-40E0-ABEB-70A87F1E5FE9Q48269838-4CF56E0B-A167-4968-A794-86A6E5D4AFCDQ48289030-67A39695-1540-49D0-A8D7-86270F7B003CQ49165436-7D736D5D-1B45-4D87-AF06-86DF41F5E415Q49312791-BC35387E-894A-480A-B895-0121A1E54E91Q50111239-0A95804E-F74E-49F3-83BC-019F0C844529Q50925364-A9DFE358-6D11-4E1F-A349-4F083B3493D7Q51016398-3AC4FCB0-1ED2-4982-8CC7-B7CD751A901BQ51055990-E415B4B8-368B-4863-8724-B331B38D7A00Q52146974-868720A0-B996-4A86-AF18-2770772DAC9C
P2860
Fetal growth restriction - from observation to intervention.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fetal growth restriction - from observation to intervention.
@en
Fetal growth restriction - from observation to intervention.
@nl
type
label
Fetal growth restriction - from observation to intervention.
@en
Fetal growth restriction - from observation to intervention.
@nl
prefLabel
Fetal growth restriction - from observation to intervention.
@en
Fetal growth restriction - from observation to intervention.
@nl
P2860
P356
P1476
Fetal growth restriction - from observation to intervention.
@en
P2093
Ahmet Alexander Baschat
P2860
P304
P356
10.1515/JPM.2010.041
P577
2010-05-01T00:00:00Z